The drug Neurontin is used as an example of why it is permissible for physicians to engage in off-label prescribing, but off-label marketing by pharmaceutical companies is prohibited by the FDA.
Increased awareness and improvement in access are needed in order to alleviate the racial disparities that exist with regard to the underutilization of hospice care by African Americans and other ethnic populations.
A new AMA policy provide guidance for physician-scientists on dual-use research issues and reinforces the message that ethical conduct in scientific research ultimately rests with the individual researcher.